3 Dividend Stocks with Monster Total Return Potential
These names stand out for their ability to pay high-yielding dividends that are growing at solid rates.
Read Moreby Matthew DiLallo, The Motley Fool | Mar 19, 2026
These names stand out for their ability to pay high-yielding dividends that are growing at solid rates.
Read Moreby Rich Duprey, Money Morning | Mar 19, 2026
With 50%+ upside potential, it remains one of the most compelling names in the AI memory super cycle.
Read Moreby David Jagielski, The Motley Fool | Mar 18, 2026
Its thirty-one consecutive years of dividend increases, make it an ideal option for long-term investors. Here’s why it can be a solid pillar to build your portfolio around.
Read Moreby Brett Owens, Contrarian Outlook | Mar 18, 2026
One pays a hefty 8.2% and has risen a stout 32% in the last decade; the other pays 11.5% and is a ‘discount in disguise.’
Read Moreby Brett Eversole, DailyWealth.com | Mar 18, 2026
History shows big gains are likely over the next year.
Read Moreby Tara Young, Trades Of The Day | Mar 18, 2026
Our target potential upside is 11%-21% in the next 3-6 months.
Read Moreby TheFly.com | Mar 18, 2026
Here are today’s upgrades and downgrades: Starbucks, Block, Constellation Brands, Trade Desk, NRG Energy, CubeSmart and more.
Read Moreby Michael Foster, Contrarian Outlook | Mar 17, 2026
Holding mainstays like Nvidia, Apple, and Microsoft, it’s outrun SPY over the last decade, and most other long-term time horizons.
Read Moreby Rich Duprey, Money Morning | Mar 17, 2026
Its entrenched franchise, accelerating AI integration, and proven execution suggest its recent selloff has overshot.
Read Moreby Derek Lewis, Zacks | Mar 17, 2026
Amid the continued AI craze in 2026, many have overlooked simple businesses, that aren’t overly flashy, but that do the ‘simple’ things exceptionally well.
Read Moreby Trades of the Day Research Team | Mar 17, 2026
On analyzing the company’s stock charts, there seem to be multiple bullish indications.
Read Moreby TheFly.com | Mar 17, 2026
Here are today’s upgrades and downgrades: Eli Lilly, Roche, Canadian Solar, Lemonade, Align Technology, W.P. Carey and more.
Read More